Pharmaceuticals

Latest Articles

Daily Agenda: Debating the Oil Rally

Andrew Barber March 9, 2016

2016-03-vitaliy-katsenelson-gilead-sciences-lab-worker-large.jpg

Gilead Sciences’ Miracle Drug Combination

Vitaliy Katsenelson February 23, 2016

Pharmaceuticals: Investor Perceptions Need to Change

Editors February 22, 2016

Daily Agenda: Oil Market Continues to Feel Supply Glut

Andrew Barber February 9, 2016

Riding Out Wild Equity Markets

Kent Hargis, Sammy Suzuki, Chris Marx February 3, 2016

2015-12-anne-szustek-deals-of-the-year-allergan-pfizer-large.jpg

Allergan-Pfizer Merger Gives Pharma a Growth Injection

Anne Szustek December 16, 2015

Inside Gilead Sciences Inc.

Specialty Pharma Drugs Raise Difficult Issues

Khadijah M Silver December 15, 2015

Pharmaceuticals Specialty: M&A Activity Will Continue to Drive Investor Interest

Editors December 1, 2015

MIT’s Andrew Lo Touts Megafund to Tackle Cancer, Rare Diseases

Kaitlin Ugolik October 26, 2015

Hedge Fund Manager Kyle Bass Declares War on Drug Prices

Jess Delaney October 22, 2015

2015-10-tom-johnson-res-aart-rising-stars-wes-golladay-jessica-fye-joseph-denardi-vamil-divan-paul-matteis-nicholas-del-deo-large.jpg

2015 All-America Research Team: Meet the Rising Stars

Carolyn Koo October 13, 2015

Martin Shkreli, Chief Investment Officer of MSMB Capital Management

Pharmaceutical Companies Gird for Drug-Price Reckoning

Kaitlin Ugolik October 8, 2015

Axovant’s Vivek Ramaswamy Aims to Reinvent Dementia Treatment

Kaitlin Ugolik September 8, 2015

Daily Agenda: Gravity Returns to Chinese Stock Market

Andrew Barber July 27, 2015

Ben Thorpe Helps Keep Goldman’s Health M&A Franchise in Top Shape

David Rothnie June 22, 2015

Fosun’s Liang Xinjun Targets Middle-Class Consumers

Allen T Cheng April 16, 2015

Daily Agenda: FOMC Signals Rate Hike Coming Soon

Andrew Barber April 9, 2015

Daily Agenda: Greek Resolution Remains Elusive

Andrew Barber March 30, 2015

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login